multiplex diagnostics
Aided by COVID-19 Funding, Firms Continued Developing Handheld Diagnostic Instruments in 2022
Premium
The lightweight, portable instruments coming onto the market employ promise to deliver test results closer to patients, potentially hastening treatments.
Becton Dickinson Gets CE-IVD Mark for BD Max Combined COVID, Flu, RSV Panel
The firm also plans to submit the assay to the US Food and Drug Administration for Emergency Use Authorization in the coming weeks.
Luminex Obtains CE Marking for MDx Panel to Detect Flu A/B, RSV, COVID-19
Results are generated in a single workflow from a patient sample, which enables rapid detection for the differential diagnosis of a single pathogen.
The firm expects to establish a US-based development and manufacturing footprint for its multiplex PCR assay kits.
The firm submitted a low-cost RT-LAMP device and COVID test to the FDA for Emergency Use Authorization this week.
Oct 2, 2020
Jul 17, 2020
Feb 11, 2020
Jan 30, 2020
Dec 18, 2019
Dec 17, 2019
ChromaCode Raises $28M in Series C Financing
May 8, 2019